+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Distinct gene alterations with a high percentage of myeloperoxidase-positive leukemic blasts in de novo acute myeloid leukemia



Distinct gene alterations with a high percentage of myeloperoxidase-positive leukemic blasts in de novo acute myeloid leukemia



Leukemia Research 65: 34-41




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 065095253

Download citation: RISBibTeXText

DOI: 10.1016/j.leukres.2017.12.006


Related references

Distinct gene alterations with a high percentage of myeloperoxidase-positive leukemic blasts in de novo acute myeloid leukemia. Leukemia Research 65: 34-41, 2018

De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study. American Journal of Hematology 89(11): E193-E199, 2014

Exocytosis of myeloperoxidase positive granules by leukemic cells in a case of acute myeloid leukemia. Japanese Journal of Clinical Electron Microscopy 24(5-6): 490-491, 1991

Expression of myeloperoxidase and gene mutations in AML patients with normal karyotype: double CEBPA mutations are associated with high percentage of MPO positivity in leukemic blasts. International Journal of Hematology 94(1): 81-89, 2011

Mesenchymal stromal cells of myelodysplastic syndrome and acute myeloid leukemia patients have distinct genetic abnormalities compared with leukemic blasts. Blood 118(20): 5583-5592, 2011

Mesenchymal stromal cells of myelodysplastic syndrome and acute myeloid leukemia patients have distinct genetic abnormalities compared with leukemic blasts. 2011

The percentage of myeloperoxidase-positive blast cells is a strong independent prognostic factor in acute myeloid leukemia, even in the patients with normal karyotype. Leukemia 17(8): 1538-1543, 2003

Induction failure in de novo acute myelogenous leukemia is associated with expression of high levels of CD34 antigen by the leukemic blasts. Leukemia and Lymphoma 26(3-4): 299-306, 1997

Expression of high Km 5'-nucleotidase in leukemic blasts is an independent prognostic factor in adults with acute myeloid leukemia. Blood 98(6): 1922-1926, 2001

Expression of the myeloperoxidase gene in AC133 positive leukemia cells relates to the prognosis of acute myeloid leukemia. Leukemia Research 30(9): 1105-1112, 2006

Correlation between myeloperoxidase expression and gene alterations and prognosis in acute myeloid leukemia. Zhonghua Xue Ye Xue Za Zhi 40(1): 40-45, 2019

The Percentage of Myeloperoxidase-Positive Blast Cells Is a Strong Independent Prognostic Factor in Acute Myeloid Leukemia, Even in the Patients with Normal Karyotype -JALSG-AML92 Study-. Blood 100(11): Abstract No 1297, 2002

C3435T polymorphism of the MDR1 gene is not associated with P-glycoprotein function of leukemic blasts and clinical outcome in patients with acute myeloid leukemia. Leukemia Research 32(10): 1601-1604, 2008

C3435T polymorphism of MDR1 gene is not associated with p-glycoprotein function of leukemic blasts and clinical outcomes in patients with acute myeloid leukemia. 2007

High incidence of deoxycytidine kinase inactivation in purified leukemic blasts of patients with cytarabine resistant acute myeloid leukemia. Blood 92(10 Suppl. 1 Part 1-2): 385A, 1998